November 14, 2023

New York, NY, November 14, 2023 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) announced today that it has partnered with Merritt Island Medical Research (“MIMR” or the “Company”). MIMR is a leading clinical research site located in Merritt Island, Florida that specializes in neuroscience related indications including Alzheimer’s Disease. The partnership represents the tenth addition to Flourish since its formation in 2021. Terms of the transaction were not disclosed. 

MIMR was founded in 2015 by leading physician, Dr. Gregory Kirk, and Co-Founders, Chelsea and Joshua Mabry and has rapidly grown to become a leading neuroscience clinical research site in Florida.  Given the local demand and its success to-date, MIMR has plans underway to expand into an additional location to continue its growth evolution. Dr. Kirk and Joshua will remain in their current roles at MIMR, while Chelsea will transition to supporting the broader Flourish platform in addition to MIMR’s success. 

Joshua Mabry, Co-Founder and CEO of MIMR, said, “I am confident that the partnership with NMS and Flourish is the ideal next step for MIMR in accelerating our growth trajectory.  We look forward to the resources and collaboration the broader platform will offer.”

Dr. Kirk stated, “We are excited to share our unique neuroscience research experience and collaborate across the Flourish sites to provide the highest quality patient care and research, with the ultimate goal of improving patient outcomes.”

Reinhold Schulz, CEO of Flourish Research, noted, “Following our partnerships with neuroscience focused sites, including AMC Research and Keystone Clinical Studies, the MIMR transaction firmly positions Flourish as a market leader in the space. We are equally excited to support the MIMR team as they expand their footprint and leverage the Flourish platform of best-in-class sites that have a strong brand and track-record of recruiting and retaining a highly diversified patient base in neuroscience related indications.”

Healthwatch Partners LLC served as financial advisor to MIMR and McDermott Will & Emery provided legal advice to NMS and Flourish.

About Flourish Research:
Flourish Research was founded to address the highly fragmented clinical trial site market. By acquiring and fully integrating best-in-class sites, Flourish provides a unique opportunity to serve sponsors and CROs with increased speed and efficiency across a variety of therapeutic areas and indications, while offering a single point of entry to multiple sites. Flourish currently has locations in Alabama, California, Florida, Illinois, North Carolina, Pennsylvania, and Texas. For additional information on Flourish, please visit our website at

About NMS Capital:
Founded in 2010, NMS Capital is an experienced private equity firm managing assets in excess of $1.4 billion. Since inception, NMS has partnered with management teams in over 100 investments and follow-on acquisitions across defined investment themes within the Business Services and Healthcare Services industries. The firm’s principal strategy is to create long-term value by providing strategic and operational resources to growth-oriented companies led by founders or experienced management teams. NMS has successfully built industry leading lower middle market companies in defensible and scalable end markets by accelerating organic and acquisition-driven growth. For additional information on NMS, please visit the firm’s website at Follow NMS Capital on

For further information:
Jonathan Spero
Vice President